 |
|
Kidney disease linked to lower medication use after heart attack
July 10, 2008Patients with kidney disease-especially end-stage renal disease (ESRD) requiring dialysis-are less likely to receive recommended medications after a heart attack, reports a study in the September 2008 Clinical Journal of the American Society of Nephrology (CJASN).
"This is the first systematic report to investigate whether kidney function is associated with use of and adherence with medications that are recommended for secondary prevention after a heart attack," comments Dr. Wolfgang C. Winkelmayer of Brigham and Women's Hospital in Boston, MA. "We found that use of several medications after a heart attack was lower in patients with chronic kidney disease (CKD) or ESRD. However, 1-year adherence did not differ by kidney function."
The researchers analyzed data on medication use after a heart attack, or myocardial infarction, in approximately 21,500 patients. Seventeen percent of the patients had CKD-loss of kidney function that, in many cases, progresses to ESRD. Another two percent had ESRD-permanent loss of kidney function requiring dialysis or transplantation.
Patients with and without kidney disease were compared for use of medications recommended after myocardial infarction: beta-blockers, angiotensin-converting enzyme inhibitors or angiotensin receptor blockers (ACEIs/ARBs), and cholesterol-lowering "statin" drugs. Along with aspirin, these three types of drugs are an important part of strategies to prevent further events after myocardial infarction.
Overall rates of medication use were low: after leaving the hospital, just 27 percent of patients filled a prescription for a statin drug. Forty-four percent started treatment with ACEIs/ARBs and 57 percent with beta-blockers.
After adjustment for other factors, patients with CKD were 22 percent less likely to start beta-blocker treatment, compared to patients without kidney disease. There was no difference in ACEI/ARB or statin use.
For ESRD patients, rates of medication use were even lower: 43 percent lower for ACEIs/ARBs and 17 percent lower for statins. (Patients with ESRD were also less likely to start beta-blocker treatment, although the difference wasn't significant.)
Among patients who filled a first prescription, rates of continued medication use after one year were 64 percent for beta-blockers, 57 percent for statins, and 54 percent for ACEIs/ARBs. For all three types of drugs, adherence rates were similar for patients with and without CKD. Patients with ESRD were less likely to continue beta-blocker treatment.
The results may help in understanding how medications affect the relationship between kidney disease and cardiovascular disease. "Kidney function is a well-established risk factor for cardiovascular events such as heart attacks and is also associated with a worse prognosis after such events," says Dr. Winkelmayer. "One possible explanation is differences in health service delivery-it may be that patients with more advanced kidney function receive less state-of-the art care after a heart attack, including less acute coronary intervention, less acute medical intervention, and less chronic, secondary prevention." The results also show some important differences in medication use after myocardial infarction by patients with kidney disease, particularly ESRD. However, these differences don't appear to explain the higher cardiovascular risk among patients with low kidney function.
Over time, rates of adherence to all three types of medications for myocardial infarction are surprisingly low-for patients with and without kidney disease. Especially as rates of kidney disease continue to rise, new ways of reducing cardiovascular risk among patients with low kidney function should be a top priority, the researchers conclude.
The study was limited by a lack of data on vital and laboratory measurements. This included tests to confirm the presence of kidney disease, which was ascertained from health care claims.
American Society of Nephrology
Patients with and without kidney disease were compared for use of medications recommended after myocardial infarction: beta-blockers, angiotensin-converting enzyme inhibitors or angiotensin receptor blockers (ACEIs/ARBs), and cholesterol-lowering "statin" drugs. Along with aspirin, these three types of drugs are an important part of strategies to prevent further events after myocardial infarction.
Overall rates of medication use were low: after leaving the hospital, just 27 percent of patients filled a prescription for a statin drug. Forty-four percent started treatment with ACEIs/ARBs and 57 percent with beta-blockers.
After adjustment for other factors, patients with CKD were 22 percent less likely to start beta-blocker treatment, compared to patients without kidney disease. There was no difference in ACEI/ARB or statin use.
For ESRD patients, rates of medication use were even lower: 43 percent lower for ACEIs/ARBs and 17 percent lower for statins. (Patients with ESRD were also less likely to start beta-blocker treatment, although the difference wasn't significant.)
Among patients who filled a first prescription, rates of continued medication use after one year were 64 percent for beta-blockers, 57 percent for statins, and 54 percent for ACEIs/ARBs. For all three types of drugs, adherence rates were similar for patients with and without CKD. Patients with ESRD were less likely to continue beta-blocker treatment.
The results may help in understanding how medications affect the relationship between kidney disease and cardiovascular disease. "Kidney function is a well-established risk factor for cardiovascular events such as heart attacks and is also associated with a worse prognosis after such events," says Dr. Winkelmayer. "One possible explanation is differences in health service delivery-it may be that patients with more advanced kidney function receive less state-of-the art care after a heart attack, including less acute coronary intervention, less acute medical intervention, and less chronic, secondary prevention." The results also show some important differences in medication use after myocardial infarction by patients with kidney disease, particularly ESRD. However, these differences don't appear to explain the higher cardiovascular risk among patients with low kidney function.
Over time, rates of adherence to all three types of medications for myocardial infarction are surprisingly low-for patients with and without kidney disease. Especially as rates of kidney disease continue to rise, new ways of reducing cardiovascular risk among patients with low kidney function should be a top priority, the researchers conclude.
The study was limited by a lack of data on vital and laboratory measurements. This included tests to confirm the presence of kidney disease, which was ascertained from health care claims.
American Society of Nephrology
Kidney Disease Current Events and Kidney Disease News RSSAnnual Report Targets Chronic Kidney Disease in the United States
A 30 percent increase in chronic kidney disease over the past decade has prompted the U.S. Renal Data System (USRDS) to issue for the first time a separate report documenting the magnitude of the disease, which affects an estimated 27 million Americans and accounts for more than 24 percent of Medicare costs.
Research suggests doctors should consider kidney-sparing surgery
A study of almost 1,500 kidney cancer patients treated at Memorial Sloan Kettering Cancer Center suggests that surgery to spare as much kidney tissue as possible may improve overall survival in patients who also have reduced kidney function at the time their cancer is diagnosed.
Minimally invasive aortic valve bypass benefits high-risk elderly patients
An uncommonly used surgical procedure that bypasses a narrowed aortic valve, rather than replacing it, effectively restores blood flow from the heart to the rest of the body and gives high-risk patients a safe alternative to conventional valve surgery.
Depressed dialysis patients more likely to be hospitalized or die, researcher finds
Dialysis patients diagnosed with depression are nearly twice as likely to be hospitalized or die within a year than those who are not depressed, a UT Southwestern Medical Center researcher has found.
Depressed dialysis patients more likely to be hospitalized or die, researcher finds
Dialysis patients diagnosed with depression are nearly twice as likely to be hospitalized or die within a year than those who are not depressed, a UT Southwestern Medical Center researcher has found.
New gene variant identified for nondiabetic end stage renal disease in African-Americans
Scientists at Johns Hopkins schools of Public Health and Medicine have, for the first time, identified variants in the gene MYH9 that are associated with increased risk for non-diabetic end stage renal disease (ESRD,) which is the near-loss of kidney function leading to either dialysis of transplant. MYH9, located on the 22 chromosome, is the first gene identified for common forms of kidney disease.
Newly found gene variants account for kidney diseases among African-Americans
For the first time, researchers have identified variations in a single gene that are strongly associated with kidney diseases disproportionately affecting African-Americans. This work was conducted by researchers at the National Institutes of Health (NIH) and by NIH-funded investigators at the Johns Hopkins University.
Listeriosis infection primer for health-care providers and the public
With the current outbreaks of listeriosis in Canada connected to deli meats and cheese, CMAJ is releasing guidelines for health care professionals and the general public about symptoms, who is at risk, symptom management, and how to reduce the risk of listeriosis.
Too much calcium in blood may increase risk of fatal prostate cancer
Men who have too much calcium in their bloodstreams may have an increased risk of fatal prostate cancer, according to a new analysis from Wake Forest University School of Medicine and the University of Wisconsin.
NYU scientists identify critical protein complex in formation of cell cilia
An international team led by NYU Cancer Institute have identified a protein complex that regulates the formation of cilia, which are found on virtually all mature human cells and are essential to normal cell function.
More Kidney Disease Current Events and Kidney Disease News Articles
 | Primer on Kidney Diseases (Greenberg, Primer on Kidney) by Arthur Greenberg As an official publication of the National Kidney Foundation (NKF), Primer on Kidney Diseases has received wide critical acclaim since it first published in 1994. Now in its 4th Edition, it continues to provide a current view of the pathophysiology, diagnosis, and management of kidney disease, fluid and electrolyte disorders, hypertension, dialysis, and renal transplantation.· Incorporates the... |
 | Coping with Kidney Disease: A 12-Step Treatment Program to Help You Avoid Dialysis by Mackenzie Walser, Betsy Thorpe A revolutionary program that can indefinitely postpone the need for dialysis If you've been diagnosed with kidney failure, this book could save your life. If you suffer from diabetes, hypertension, obesity, or any of a host of conditions that put you at risk for kidney disease, you owe it to yourself to read what is in this book. If you are among the 60,000 North Americans who go on... |
 | The Vegetarian Diet For Kidney Disease Treatment: Preserving Kidney Function With Plant Based Eating by Joan Brookhyser Whether you are currently a vegetarian or just searching for a safe diet to follow with kidney disease, this book is for you. Based on the author's 20 years of experience in nutrition counseling for chronic kidney disease, this book provides easy to follow guidelines for plant based eating, to help slow down kidney function decline while keeping you healthy. Nutrition guidelines for different... |
 | Living Well with Kidney Disease by National Kidney Foundation of Southern California The first edition of "Living Well With Kidney Disease" was developed and published by the National Kidney Foundation of Southern California. Based on the handbook "When Your Kidneys Fail" (originally published in 1982), this new and updated edition provides detailed information specifically intended for people coping with Kidney Disease and other renal failure, as well as their friends and... |
 | Eating Well-Living Well with Kidney Disease: Dietary Approaches to Healthy Living (Eating Well-Living Well) by Duke University A thorough nutritional resource from a leading research facility includes an explanation of kidney disease, practical advice on how to choose and eat the right foods, plus recipes to make changing eating habits... |
| Handbook of Drug Therapy in Liver and Kidney Disease by Schrier Organized by drug classifications, the book provides detailed information on the pharmacokinetic behavior of the most commonly used... | |
| Kidney Friendly Comfort Foods, New Updated Version: A Collection of Recipes for Eating Well with Chronic Kidney Disease by Shire US Inc. | |
 | More Bio-Fuel --- Less Bio-Waste: Dietary Creatine Reduction Self-Help Guide for People With Kidney Impairment by Wendy Lou Jones More than 250,000 persons in the USA alone (and millions worldwide) have some form of end stage renal disease (ESRD). For the hundreds of thousands who must undergo dialysis to stay alive, excessive serum creatinine—the metabolic "waste" product of creatine, a natural component of meat, contributes to the vicious cycle of nausea, vomiting, anorexia and diminished quality of life experienced... |
 | ABC of Kidney Disease (ABC Series) The ABC of Kidney Disease is a brand new title in the successful ABC series which explains this complicated area thoroughly and clearly, in a practical and user-friendly manner. Providing information on a wide variety of renal diseases, this book ensures non-renal healthcare workers are able to screen, identify, treat and refer renal patients appropriately. Covering signs, symptoms,... |
 | Kidney Friendly Comfort Foods: A Collection of Recipes for Eating Well with Chronic Kidney Disease Fending off phosphorus doesn’t have to mean fending off flavor. The Kidney Friendly Comfort Foods: A Collection of Recipes for Eating Well with Chronic Kidney Disease cookbook features 21 low-phosphorus recipes developed by a certified chef de cuisine who is also a nutritionist and reviewed by a renal dietitian. Every recipe puts a low-phosphorus spin on an old favorite and is adjusted for... |
| © 2008 BrightSurf.com |